To the Editor:

We would like to thank Antaki and colleagues for their precious contribute and for their interest in our work [1]. In their recent considerable research, Dirani et al. retrospectively evaluated the role of 360° intraoperative laser retinopexy for the prevention of retinal re-detachment in patients treated with pars plana vitrectomy [2].

In our interventional, prospective, randomized study, we compared the efficacy of intraoperative localized and 360° laser retinopexy in cases of rhegmatogenous retinal detachment (RRD) treated with pars plana vitrectomy and air tamponade. We agree with the authors regarding the inhomogeneity of the results of the published studies on the topic.

For sample size calculation we estimated the effect size using the results of previous studies who employed laser retinopexy in eyes with retinal detachment. In cases of retinal detachment in silicone oil-filled eyes, Zhou et al. treated 26 patients with circumferential laser photocoagulation and 22 subjects with localized laser photocoagulation. Single-operation success rates were of 92.31% and 59.09%, respectively [3]. In 2017, Zhou et al. retrospectively analysed the medical records of 48 cases of retinal detachment with undetected breaks. Single-operation reattachment rate was 89.47% in the 19 eyes who underwent 360° laser retinopexy and 55.17% in the 29 patients treated with localized laser retinopexy [4]. Based on these results we estimated an effect size of ~30% and calculated that 42 patients were required for each group, with a power of 80% and a significance level of 0.05.

We considered that results from studies that analysed the use of laser retinopexy in cases of retinal detachment were more appropriate for our purposes than studies that compared combined pars plana vitrectomy/scleral buckling with vitrectomy alone.

We believe that the increasing interest in the topic should be welcomed and hope it will represent a step forward for the management of uncomplicated cases of RRD.